Rhinovirus Infections

Disease

Related News

Age-Related Infectious Disease Risks: Rhinovirus, Polypharmacy, and COVID-19 Treatment Patterns

Jun 26, 2026

Studies reveal age-related infectious disease patterns including higher symptomatic rhinovirus risk in adults over 60, polypharmacy complications in infectious disease patients, and significant underutilization of COVID-19 antivirals among older adults despite proven benefits.

Altesa Raises $75M Series B to Advance Rhinovirus Treatment for COPD Patients

Mar 19, 2026

Altesa BioSciences closed an oversubscribed $75 million Series B financing led by Forbion with participation from Sanofi to advance vapendavir, a first-in-class oral antiviral targeting rhinovirus infections in COPD patients.